Compare Cardinal Health Inc (CAH) vs Enveric Biosciences Inc (ENVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs Enveric Biosciences Inc — how do they compare? Cardinal Health Inc trades at $240.57 (market cap $55.88B), while Enveric Biosciences Inc trades at $1.45 (market cap $6.20M). The key difference: Cardinal Health Inc is far larger — about 9012.9× Enveric Biosciences Inc's market cap, and Cardinal Health Inc pays a 0.86% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| CAH | ENVB | |
|---|---|---|
Market Cap | $55.88B | $6.20M |
Sector | Health | Health |
52-Week High | $240.26 | $17.40 |
52-Week Low | $146.04 | $1.27 |
Enterprise Value | $59.91B | $1.30M |
Dividend Yield | 0.86% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →
